Diet-induced Obesity Alters Signalling Pathways and Induces Atrophy and Apoptosis in Skeletal Muscle in a Prediabetic Rat Model
Overview
Authors
Affiliations
Pro-inflammatory and stress-activated signalling pathways are important role players in the pathogenesis of obesity and insulin resistance. Obesity and type II diabetes are associated with chronic, low-grade inflammation and elevated tumour necrosis factor-α (TNF-α) levels. There is increasing evidence that TNF-α may play a critical role in skeletal muscle atrophy. However, the effects of obesity-induced insulin resistance on these signalling pathways are poorly understood in skeletal muscle. Therefore, the present study addressed the effects of obesity-induced insulin resistance on the activity of the ubiquitin ligases, nuclear factor-B, p38 MAPK and phosphoinositide 3-kinase signalling pathways in the gastrocnemius muscle and compared these with muscle of standard chow-fed control rats. Male Wistar rats were randomly allocated to a control diet group (standard commercial chow; 60% carbohydrates, 30% protein and 10% fat) or a cafeteria diet group (65% carbohydrates, 19% protein and 16% fat) for 16 weeks. Blood analysis was conducted to determine the impact of the model of obesity on circulating insulin, glucose, free fatty acids, TNF-α and angiotensin II concentrations. The experimental animals were 18% heavier and had 68% greater visceral fat mass than their control counterparts and were dyslipidaemic. Significant increases in the ubiquitin ligase and MuRF-1, as well as in caspase-3 and poly-ADP-ribose polymerase cleavage were observed in the muscle of obese animals compared with the control rats. We propose that dyslipidaemia may be a mechanism for the activation of inflammatory/stress-activated signalling pathways in obesity and type II diabetes, which will lead to apoptosis and atrophy in skeletal muscle.
Wu Y, Yang Y, Du C, Peng X, Fan W, Chang B Sci Rep. 2025; 15(1):4918.
PMID: 39930016 PMC: 11811154. DOI: 10.1038/s41598-025-89297-2.
Velasco-Gutierrez J, de Alvarez-Buylla E, Montero S, Rodriguez-Hernandez A, Miranda S, Martinez-Santillan K Biomedicines. 2025; 13(1).
PMID: 39857710 PMC: 11763071. DOI: 10.3390/biomedicines13010126.
Salagre D, Navarro-Alarcon M, Gonzalez L, Elrayess M, Villalon-Mir M, Haro-Lopez R Antioxidants (Basel). 2025; 14(1).
PMID: 39857351 PMC: 11762543. DOI: 10.3390/antiox14010016.
Pan C, Yang Y, Zhao Z, Hu J Apoptosis. 2025; .
PMID: 39833631 DOI: 10.1007/s10495-024-02069-7.
Di Porzio A, Barrella V, Cigliano L, Mauriello G, Troise A, Scaloni A Pflugers Arch. 2024; 477(2):223-239.
PMID: 39537965 DOI: 10.1007/s00424-024-03041-9.